Pfizer
NEWS
On Wednesday, KBR reported that a male employee at Novartis Korea reported to the company that his female boss sexually harassed him in September.
As 2017 comes to a close, 40 drugs have been approved so far, with the record being in 2015, when 46 drugs were approved.
A look at the FDA’s long-awaited guidelines on how it will regulate regenerative medicine products, including stem cells.
Genentech is claiming that Pfizer’s proposed biosimilar infringes 40 of its patents.
The FDA approved a label expansion for Pfizer’s cancer drug Sutent to include the adjuvant treatment of adult patients at high risk of RCC following the surgical removal of the cancerous kidney.
The company sold the stake to Sapphire I Holdings at an undisclosed price.
Investors love to speculate on M&A, and one of the hottest topics of speculation recently has been whether someone will buy BMS.
Pfizer is planning to hire 200 new staffers and another 200 replacement workers in Michigan.
Earlier this month, Pfizer’s chairman and CEO, Ian Read, said he was considering selling the company’s Consumer Healthcare business, or possibly spinning it off.
JOBS
IN THE PRESS